Mankind Pharma Allots Shares Under ESOPs
By Ankur Chandra | Updated at: May 31, 2025 10:45 PM IST
Mankind Pharma Limited has announced the allotment of 92,512 equity shares under its Employee Stock Option Plan 2022 (ESOP 2022). The shares were granted to eligible employees who exercised their stock options, as per the resolution passed by the Nomination and Remuneration Committee during its meeting held on May 21.
Key Highlights of the Allotment:
| Particulars | Details |
|---|---|
| Number of shares allotted | 92,512 |
| Face value per share | ₹1 |
| Exercise price per share | ₹860 |
| Premium per share | ₹859 |
| Post-allotment total equity shares | 41,26,71,039 |
| Increase in paid-up share capital | From ₹41,25,78,527 to ₹41,26,71,039 |
| ISIN | INE634S01028 |
| Distinctive numbers | 41,25,78,528 to 41,26,71,039 |
All the newly issued equity shares will rank pari-passu with the existing equity shares of the company, carrying equal rights and entitlements.
The ESOP allotment was executed following Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The company confirmed that there is no lock-in period on the allotted shares, and no listing fees are applicable for this issue. The equity shares will continue to be listed and traded on both the NSE and BSE.
Stock Performance:
Shares of Mankind Pharma have gained 21% in the last year, a 12% dip in the YTD, and a 2.27% dip in the last month.
About Mankind Pharma:
Mankind Pharma, an Indian multinational based in New Delhi, is one of the top pharmaceutical companies in India with a diverse product portfolio ranging from Pharma to FMCG. The company’s trusted products help millions around the world in critical areas such as antibiotics, gastrointestinal, cardiovascular, and skin health.
Ref:https://nsearchives.nseindia.com/corporate/MANKIND4_21052025104750_ESOPallotment21052025_sd.pdf
